viewSyngenta AG (ADR)

Syngenta AG unveils $6bn product pipeline to appease investors

Syngenta is working to build investor confidence in its go-it-alone strategy.

Syngenta AG (NYSE:SYT), which turned down a $4bn bid from Monsanto (NYSE:MON), said it’s speeding up the pace of innovation and has a pipeline of new technology with combined sales potential of more than $6bn.

The products include fungicides Adepidyn and Orondis that can be used on vegetables and specialty crops. 

The agrochemical supplier said it has also made progress developing hybrid wheat, a product that could go on sale by the 2020 and have annual sales of more than $3bn.

Syngenta is working to build investor confidence in its go-it-alone strategy. Management has come under increasing pressure from shareholders after it rejected Monsanto's offer which the St. Louis, Missouri-based company had valued at 470 Swiss francs ($488) a share, or roughly $46bn.

In its efforts to appease investors, Syngenta has already announced plans to sell its vegetable seeds business in the next 12 months and a $2bn share buyback.

ADRs of Syngenta climbed 0.6% to $69.79 at 10 a.m. in New York. The stock has gained 8.9% this year.

Quick facts: Syngenta AG (ADR)

Price: - -

Market: NYSE
Market Cap: -

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



Alpha Growth PLC using experienced team to start Alpha Growth and Income...

Alpha Growth PLC (LON: ALGW) CEO Gobind Sahney joined Steve Darling from Proactive to discuss the fund called Alpha Growth and Income fund or AGI. This funds prospective client are family offices, pension funds, and other institutions that still wish to receive some income but also want their...

1 day, 7 hours ago

2 min read